Document And Entity Information [Abstract] Document Information [Table] Class of Stock [Axis] Document Type Amendment Flag Document Period End Date Document Fiscal Year Focus Document Fiscal Period Focus Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Accrued Expenses [Abstract] Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accrued Expenses Earnings Per Share [Abstract] Earnings Per Share [Text Block] Loss Per Share Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Stock-Based Compensation Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Product Information [Table Text Block] Product Development Pipeline Schedule Of Accrued Liabilities Table [Text Block] Accrued Expenses Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Calculation of Loss Per Share Schedule of Product Information [Table] Products and Services [Axis] Products and Services [Domain] Enclomiphene [Member] Proellex [Member] Products Or Services Secondary Categorization [Axis] Products Or Services Secondary Categorization [Domain] Secondary Hypogonadism [Member] Uterine Fibroids 1 [Member] Uterine Fibroids [Member] Endometriosis [Member] Product Information [Line Items] Product Information [Line Items] Product Status Status Product Status Product Next Expected Milestone Next Expected Milestone(s) Product Next Expected Milestone Legal Entity [Axis] Entity [Domain] Subsidiary, Sale of Stock [Axis] Sale of Stock, Name of Transaction [Domain] Development Stage Enterprise Deficit Accumulated During Development Stages Deficit accumulated during the development stage Cumulative net losses reported during the development stage. Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Statement Of Financial Position [Abstract] Statement [Table] Class of Stock [Domain] Statement [Line Items] Assets [Abstract] ASSETS Assets Current [Abstract] Current Assets Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current, Total Total current assets Property, Plant and Equipment, Net, Total Fixed assets, net Net Fixed Assets Assets, Total Total assets Total assets Liabilities and Stockholders Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities Current [Abstract] Current Liabilities Accounts Payable Current Accounts payable Accrued Expenses Accrued expenses Total Liabilities, Current, Total Total current liabilities Commitments and Contingencies Commitments and contingencies (note 6) Stockholders Equity [Abstract] Stockholders' Equity Preferred Stock Value Undesignated Preferred Stock, $.001 par value, 5,000,000 shares authorized, none issued and outstanding Common Stock Value Common Stock, $.001 par value, 75,000,000 shares authorized, 24,430,461 and 24,388,523 shares issued, respectively and 24,318,111 and 24,276,173 shares outstanding, respectively Additional Paid in Capital, Total Additional paid-in capital Treasury Stock Value Cost of treasury stock, 112,350 shares Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders Equity Attributable to Parent, Total Total stockholders' equity Balance Shareholders’ Equity Balance Total stockholders’ equity Liabilities and Equity, Total Total liabilities and stockholders' equity Schedule Of Accrued Liabilities [Table] Schedule of Accrued Liabilities [Table] Schedule Of Accrued Liabilities [Line Items] Schedule of Accrued Liabilities [Line Items] Accrued Research and Development Expense Current Research and development costs Accrued Research and Development Expense, Current Accrued Personnel Expense Current Personnel related costs Accrued Personnel Expense Current Other Accrued Liabilities Current Other Net Income (Loss) Attributable to Parent, Total Net loss Net loss Net loss Weighted Average Number Of Shares Outstanding, Basic and Diluted Weighted average common shares outstanding Shares used in loss per share calculation Earnings Per Share, Basic and Diluted, Total Basic and diluted loss per share Loss per share - basic and diluted: Net loss per share - basic and diluted Loss per share - basic and diluted Earnings Per Share Disclosure [Table] Series Warrant [Member] Series A Warrants [Member] Series B Warrant [Member] Series B Warrants [Member] Series B Warrant Range [Axis] Class of Warrant or Right, Number of Securities Called by Warrants or Rights Anti-dilutive shares of common stock excluded from computation of earning per share Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants, exercise price per share Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Plan Name [Axis] Plan Name [Domain] Two Thousand And Eleven Equity Incentive Plan [Member] 2011 Equity Incentive Plan Member Domain plan member Vesting [Axis] Vesting [Domain] Share-based Compensation Award, Tranche One [Member] Vested Options One [Member] Share-based Compensation Award, Tranche Two [Member] Vested Options Two [Member] Related Party [Axis] Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Stock Options, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Stock Options, Forfeited/cancelled Commitments and Contingencies [Table] Commitments and Contingencies [Table] Related Party [Domain] Third Party [Member] Third Party [Member] Third Party [Member] Geographical [Axis] Geographical [Domain] Foreign [Member] Foreign [Member] Foreign Title of Individual [Axis] Issued Patent Number Issued patent number during the period. Gain Contingency, Patents Found Infringed upon, Number Number of patents Undesignated Preferred Stock [Member] Preferred Stock, Par or Stated Value Per Share Preferred Stock, par value Preferred Stock Shares Authorized Preferred Stock, shares authorized Preferred Stock Shares Issued Preferred Stock, issued Preferred Stock Shares Outstanding Preferred Stock, outstanding Common Stock, Par or Stated Value Per Share Common Stock, par value Common Stock Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding Treasury Stock Shares Treasury stock, shares Income Statement [Abstract] Revenues [Abstract] Revenues Investment Income, Interest Interest income Interest income Revenues, Total Total revenues and other income Costs and Expenses [Abstract] Expenses Expenses: Research and Development Expense, Total Research and development Research and development General and Administrative Expense, Total General and administrative General and Administrative Costs and Expenses, Total Total expenses Total expenses Weighted Average Number Of Shares Outstanding [Abstract] Weighted average shares used in loss per share calculation: Weighted Average Number of Shares Outstanding, Basic, Total Basic Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Diluted Weighted Average Number of Shares Outstanding, Diluted Statement Of Stockholders' Equity [Abstract] Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Treasury Stock [Member] Shares, Issued Balance (in shares) Balance (in shares) Adjustments To Additional Paid In Capital, Share-Based Compensation, Stock Options, Requisite Service Period Recognition Stock based compensation StockIssuedDuringPeriodValueWarrantsExercisedCash Exercise of 37,093 Series A warrants to purchase common stock for cash @ $0.01 per share Stock issued during period for exercise value of warrants. StockIssuedDuringPeriodSharesWarrantsExercisedCash Exercise of 37,093 Series A warrants to purchase common stock for cash @ $0.01 per share (in shares) Stock issued during period for exercise value of warrant. Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Issuance of shares of common stock for the cashless exercise of stock options Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures, Total Issuance of shares of common stock for the cashless exercise of stock options (in shares) Stock Issued During Period, Value, Stock Options Exercised Exercise of stock options to purchase common stock stock for cash ($1.56 to $9.60 per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercise of stock options to purchase common stock stock for cash ($1.56 to $9.60 per share) (in shares) Stock Issued During Period Value Warrants Exercised Cashless Issuance of 562,222 shares of common stock for the cashless exercise of 562,523 Series A Warrants Stock Issued During Period, Value, Warrants Exercised Cashless Stock Issued During Period Shares Warrants Exercised Cashless Issuance of 562,222 shares of common stock for the cashless exercise of 562,523 Series A Warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised Cashless Stock Issued During Period Value Warrants Exercised Cashless1 Issuance of 329,753 shares of common stock for the cashless exercise of 380,101 Series B Warrants Stock Issued During Period, Value, Warrants Exercised Cashless1 Stock Issued During Period Shares Warrants Exercised Cashless1 Issuance of 329,753 shares of common stock for the cashless exercise of 380,101 Series B Warrants (in shares) Stock Issued During Period, Shares, Warrants Exercised Cashless1 Issuance [Axis] Eequity issuances [Domain] Range [Domain] Maximum [Member] Minimum [Member] Auction Market Preferred Securities, Stock Series [Axis] Stock Issued During Period Shares Warrants Exercised Issuance of shares of common stock for the cashless exercise of Series A Warrants stock options Number of warrants exercised during the current period. Stock Issued During Period Shares Warrants Exercised1 Issuance of shares of common stock for the cashless exercise of Series B Warrants stock options Number of warrants exercised during the current period1. Common StockOption Shares Issuance of shares of common stock for the cashless exercise of stock options Common Stock Option Shares Statement Of Cash Flows [Abstract] Net Cash Provided By Used In Operating Activities [Abstract] Cash Flows from Operating Activities Depreciation, Depletion and Amortization, Nonproduction, Total Depreciation and amortization Share-based Compensation, Total Noncash stock-based compensation Increase (Decrease) in Prepaid Expense and Other Assets, Total (Increase) decrease in prepaid expenses and other current assets Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total Increase (decrease) in accounts payable and accrued expenses Adjustments Noncash Items To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Net Cash Provided by (Used in) Operating Activities, Total Net cash used in operating activities Net cash used in operating activities Net Cash Provided By Used In Investing Activities [Abstract] Cash Flows from Investing Activities Payments to Acquire Property, Plant, and Equipment, Total Capital expenditures Net Cash Provided by (Used in) Investing Activities, Total Net cash used in investing activities Net cash used in investing activities Net Cash Provided By Used In Financing Activities [Abstract] Cash Flows from Financing Activities Proceeds from Stock Options Exercised Exercise of stock options & warrants Proceeds From Contributed Capital Proceeds from a shareholder transaction Net Cash Provided by (Used in) Financing Activities, Total Net cash provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease), Total Net decrease in cash and cash equivalents Organization Consolidation and Presentation Of Financial Statements Disclosure [Text Block] Organization, Operations and Liquidity Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued expenses Auction Market Preferred Securities, Stock Series, Title [Domain] Use of Estimates, Policy [Policy Text Block] Critical Accounting Policies and the Use of Estimates Accrued Expenses Policy [Policy Text Block] Accrued Expenses Disclosure of accounting policy for the components of accrued expenses. Research and Development Expense, Policy [Policy Text Block] Research And Development Expense Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Stock-Based Compensation Income Tax, Policy [Policy Text Block] Income Taxes Gain Contingency, Patents Found Not Infringed upon, Number Number of pending patent applications Commitments and Contingencies [Line Items] Commitments and Contingencies [Line Items] Commitments and Contingencies [Line Items] Relationship to Entity [Domain] Chief Executive Officer [Member] Joseph S. Podolski Executive Vice President [Member] Ron Wiehle Inventor [Member] Dr. Harry Fisch Retained Earnings [Member] Accumulated Deficit [Member] Quantifying Prior Year Misstatements Corrected in Current Year Financial Statements [Abstract] REVISION OF PRIOR YEARS’ FINANCIAL STATEMENTS [Abstract] Revision Of Prior Years Financial Statements [Text Block] Revision Of Prior Years’ Financial Statements The entire disclosure for reporting revision of prior years financial statements. Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Schedule of Error Corrections and Prior Period Adjustments Schedule Of Error Corrections And Prior Period Adjustments Cash flows [Table Text Block] Schedule Of Error Corrections And Prior Period Adjustments Cash flows Tabular disclosure of prior period adjustments to Consolidated statement of cash flows. Schedule of Quantifying Prior Year Misstatement Corrected in Current Year Financial Statements [Table] Scenario [Axis] Quantifying Misstatement in Current Year Financial Statements [Line Items] Scenario, Unspecified [Domain] Scenario, Previously Reported [Member] As Previously Reported [Member] Common Stock Price Per Share Common Stock Price Per Share. Stock option exercise price Exercise of stock option to purchase common stock for cash, share price Stock option exercise price.